Ketorolac Tromethamine is considered what type of medication?

Ketorolac Tromethamine is primarily classified as a systemic analgesic. It is a nonsteroidal anti-inflammatory drug (NSAID) that provides significant pain relief and is commonly used for short-term management of moderate to severe pain. While it can be administered by various routes, including orally, intramuscularly, and intravenously, its primary indication is for its analgesic properties rather than as a topical treatment.

Although there are formulations of ketorolac available for topical use, such as in ophthalmic solutions for managing pain and inflammation following cataract surgery, the most accurate classification of ketorolac itself is as a systemic analgesic. Its effectiveness in pain management stems from its ability to inhibit the enzyme cyclooxygenase (COX), thereby reducing prostaglandin synthesis, which is responsible for pain and inflammation.

While other options like topical NSAIDs and oral NSAIDs also relate to pain management, these terms do not encompass the systemic usage and primary application of ketorolac in treating pain. Therefore, identifying ketorolac as primarily a systemic analgesic captures its essential characteristics and intended clinical use.